Guy Storme
Overview
Explore the profile of Guy Storme including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
3190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghimire H, Malekzadeh M, Lim J, Madabushi S, Zampini M, Camacho A, et al.
bioRxiv
. 2025 Jan;
PMID: 39803423
Background/objectives: Bone marrow (BM) adipocytes are critical in progressing solid tumor metastases and hematological malignancies across pediatric to aging populations. Single-point biopsies remain the gold standard for monitoring BM diseases,...
2.
Storme G
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38275862
Despite our increasing understanding of the biology and evolution of the cancer process, it is indisputable that the natural process of cancer creation has become increasingly difficult to cure, as...
3.
Van Parijs H, Cecilia-Joseph E, Gorobets O, Storme G, Adriaenssens N, Heyndrickx B, et al.
Front Oncol
. 2023 Dec;
13:1211544.
PMID: 38053657
Background: TomoBreast hypothesized that hypofractionated 15 fractions/3 weeks image-guided radiation therapy (H-IGRT) can reduce lung-heart toxicity, as compared with normofractionated 25-33 fractions/5-7 weeks conventional radiation therapy (CRT). Methods: In a...
4.
Hui S, Storme G, Wong J, Aristei C, Al Malki M, Aydogan B
Front Oncol
. 2023 Aug;
13:1240530.
PMID: 37538119
No abstract available.
5.
Vinh-Hung V, Gorobets O, Adriaenssens N, Van Parijs H, Storme G, Verellen D, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551726
We investigated lung-heart toxicity and mortality in 123 women with stage I-II breast cancer enrolled in 2007-2011 in a prospective trial of adjuvant radiotherapy (TomoBreast). We were concerned whether the...
6.
Lim J, Madabushi S, Vishwasrao P, Song J, Abdelhamid A, Ghimire H, et al.
Front Oncol
. 2022 Nov;
12:1045016.
PMID: 36439420
Total body irradiation (TBI) is a commonly used conditioning regimen for hematopoietic stem cell transplant (HCT), but dose heterogeneity and long-term organ toxicity pose significant challenges. Total marrow irradiation (TMI),...
7.
Verbanck S, Van Parijs H, Schuermans D, Vinh-Hung V, Storme G, Fontaine C, et al.
Int J Radiat Oncol Biol Phys
. 2022 Mar;
113(3):561-569.
PMID: 35227790
Purpose: Previous studies in patients with breast cancer have shown acute radiation therapy-induced reductions of pulmonary diffusing capacity, essentially owing to lung volume restriction. We aimed to assess the long-term...
8.
Brooks J, Zuro D, Song J, Madabushi S, Sanchez J, Guha C, et al.
Int J Radiat Oncol Biol Phys
. 2021 Nov;
112(4):951-963.
PMID: 34767936
Purpose: Recent initial findings suggest that radiation therapy improves blood perfusion and cellular chemotherapy uptake in mice with leukemia. However, the ability of radiation therapy to influence drug accumulation in...
9.
Van Parijs H, Vinh-Hung V, Fontaine C, Storme G, Verschraegen C, Nguyen D, et al.
BMC Cancer
. 2021 Nov;
21(1):1177.
PMID: 34736429
Background: Long-term prospective patient-reported outcomes (PRO) after breast cancer adjuvant radiotherapy is scarce. TomoBreast compared conventional radiotherapy (CR) with tomotherapy (TT), on the hypothesis that TT might reduce lung-heart toxicity....
10.
Zuro D, Madabushi S, Brooks J, Chen B, Goud J, Salhotra A, et al.
Int J Radiat Oncol Biol Phys
. 2021 Jun;
111(3):671-683.
PMID: 34119592
Purpose: Total marrow irradiation (TMI) has significantly advanced radiation conditioning for hematopoietic cell transplantation in hematologic malignancies by reducing conditioning-induced toxicities and improving survival outcomes in relapsed/refractory patients. However, the...